Literature DB >> 7459779

Urinary incontinence due to interaction of phenoxybenzamine and alpha-methyldopa.

P G Fernandez, S Sahni, B A Galway, S Granter, J McDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7459779      PMCID： PMC1705150     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Neurogenic bladder.

Authors:  E BORS
Journal:  Urol Surv       Date:  1957-06

2.  Treatment of autonomic dysreflexia with phenoxybenzamine.

Authors:  J McGuire; F M Wagner; R M Weiss
Journal:  J Urol       Date:  1976-01       Impact factor: 7.450

3.  Adrenergic influence on the internal urinary sphincter.

Authors:  S Raz
Journal:  Isr J Med Sci       Date:  1974-06

4.  The physiology of the internal urinary sphincter.

Authors:  F J Kleeman
Journal:  J Urol       Date:  1970-10       Impact factor: 7.450

5.  Suppression of Raynaud's phenomenon by methyldopa.

Authors:  D P Varadi; A M Lawrence
Journal:  Arch Intern Med       Date:  1969-07

6.  Methyldopa in treatment of neurogenic bladder disorders.

Authors:  S Raz; J J Kaufman; G W Ellison; L W Mayers
Journal:  Urology       Date:  1977-02       Impact factor: 2.649
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.